Die Bedeutung freier Fettsäuren für die Regulation der hepatischen Glukoneogenese des Menschen / Dissertant: Harald Stingl

eng: Healthy, lean subjects (n=6) were infused with lipid/heparin (FFA: 2.8 #+- # 0.3 mM; glycerol: 0.5 #+-# 0.1 mM) and glycerol during 9 hours (= control; 0.6 #+-# 0.1 mM; 0.5 #+-# 0.0 mM). During lipid infusion, plasma insulin concentrations rose by #approx#50 % (p;0.05), but neither endogenous...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:[2000]
Year of Publication:2000
Language:German
Subjects:
Online Access:
Physical Description:VI, 125 Bl.; Ill., graph. Darst.
Notes:Zsfassung in engl. Sprache
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03284nam#a2200373zc#4500
001 990000320010504498
005 20230918133735.0
007 tu
008 000315|2000####|||######m####|||#|#ger#c
009 AC02934439
015 |a OeBB  |2 oeb 
035 |a (AT-OBV)AC02934439 
035 |a AC02934439 
035 |a (Aleph)002931466ACC01 
035 |a (DE-599)OBVAC02934439 
035 |a (EXLNZ-43ACC_NETWORK)990029314660203331 
040 |a ZBM  |b ger  |d AGBA  |e rakwb 
041 |a ger 
044 |c XA-AT 
084 |a QU 90  |2 nlm 
084 |a WK 810  |2 nlm 
100 1 |a Stingl, Harald Alexander  |4 aut 
245 1 0 |a Die Bedeutung freier Fettsäuren für die Regulation der hepatischen Glukoneogenese des Menschen  |c Dissertant: Harald Stingl 
264 1 |c [2000] 
300 |a VI, 125 Bl.  |b Ill., graph. Darst. 
500 |a Zsfassung in engl. Sprache 
502 |a Wien, Univ., Diss., 2000 
520 |a eng: Healthy, lean subjects (n=6) were infused with lipid/heparin (FFA: 2.8 #+- # 0.3 mM; glycerol: 0.5 #+-# 0.1 mM) and glycerol during 9 hours (= control; 0.6 #+-# 0.1 mM; 0.5 #+-# 0.0 mM). During lipid infusion, plasma insulin concentrations rose by #approx#50 % (p;0.05), but neither endogenous glucose production (EGP, estimated with D-[6,6-"2H_2]-glucose) nor fractional gluconeogenesis (GNG, "2H enrichments in C5/C2 of blood glucose following "2H_2O ingestion) were different from control studies. During somatostatin-insulin-glucagon clamp tests at postabsorptive plasma insulin (#approx#35 pM) and glucagon (#approx#90 ng/ml) concentrations, plasma glucose increased by #approx#50 % (p;0.005) during lipid infusion. Rates of EGP remained unchanged (#approx#9.5 #mu#mol*kg"-"1min"-"1). GNG was 62 #+-# 5 % (lipid) and 60 #+-# 6 % (glycerol) at 0 min and dose (p;0.005) to 74 #+-# 3 % during lipid infusion (540 min, p;0.05 vs. glycerol: 64 #+-# 4 %). In a second study, healthy subjects were infused with lipid/heparin (FFA: 2.2 #+-# 0.1 mM; glycerol: 0.5 #+-# 0.03 mM; n=7) , glycerol (0.4 #+-# 0.1 mM; 1.5 #+-# 0.2 mM, n=5) and saline (0.5#+-#0.1 mM; 0.2 #+-# 0.02 mM; n=7). Rates of GNG were calculated by subtracting rates of net glycogen breakdown (decrease of liver glycogen, 9 h, "1"3C NMR spectroscopy) from EGP. EGP decreased by #approx#25 % during lipid and saline, but not during glycerol infusion (p;0.001 vs. lipid, saline). Elevation of plasma FFA or glycerol increased GNG to 96 #+-# 2 % (p;0.001) and 86 #+-# 3 % (p;0.01 vs. saline: 70 #+-# 4 %), respectively. When the lipid-induced rise of portal vein insulin concentrations (p;0.05) was matched employing somatostatin-insulin-glucagon clamps (n=5), GNG (66 #+- # 3 %) did not differ from saline studies. In conclusion, FFA elevation markedly augments GNG without affecting EGP. This effect is neither due to (i) the lipid-induced rise in insulin secretion nor to (ii) increased glycerol availability alone, since very high glycerol concentrations were required for a comparable increase in fractional GNG.  
689 0 0 |a Leber  |D s  |0 (DE-588)4034933-0 
689 0 1 |a Gluconeogenese  |D s  |0 (DE-588)4157668-8 
689 0 2 |a Fettsäuren  |D s  |0 (DE-588)4154233-2 
689 0 |5 AT-OBV  |5 ONBREB 
856 4 2 |m V:AT-OBV;B:AT-UBMUW  |q application/pdf  |u http://media.obvsg.at/AC02934439-1001  |x ZBM  |3 Inhaltsverzeichnis  |o OBV-EDOC 
970 1 |c 34 
970 2 |a  ZBM  |d HS-DISS 
ADM |b 2024-03-23 11:37:34 Europe/Vienna  |d 20  |f System  |c marc21  |a 2018-12-24 09:50:25 Europe/Vienna  |g false 
HOL 8 |b YWOAW  |h  28705-C.Stip.   |c MAG1-3  |8 2221756330004498 
852 8 |b YWOAW  |c MAG1-3  |h  28705-C.Stip.   |8 2221756330004498 
ITM |9 2221756330004498  |e 1  |m BOOK  |b +YW707302  |i 2000:463  |2 MAG1-3  |o 20000322  |8 2321756300004498  |f 02  |p 2000-03-22 01:00:00 Europe/Vienna  |h 28705-C.Stip.  |1 YWOAW  |q 2022-06-09 11:44:14 Europe/Vienna